Phase II clinical trial of neoadjuvant alternating doublet chemotherapy with ifosfamide/doxorubicin and etoposide/cisplatin in small-cell urothelial cancer.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples